Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026)
Agenus' (AGEN) quarterly Change in Acquisitions & Divestments came in at $7000.0 in Q1 2026, down 88.71% year-on-year from $62000.0 in Q1 2025, and up 111.29% quarter-over-quarter from -$62000.0 in Q4 2025.
Agenus (AGEN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Agenus' Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 88.71% year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was -$55000.0, a 114.59% decrease from a year earlier, with the FY2024 full-year figure at $579000.0, up 1602.94% from the prior year.
- Change in Acquisitions & Divestments grew to $7000.0 in Q1 2026 per AGEN's latest filing, from -$62000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $15.0 million in Q3 2023 and bottomed at -$30.0 million in Q4 2023.
- The 5-year median for Change in Acquisitions & Divestments is $264000.0 (2024), against an average of $1.7 million.
- Biggest YoY gain for Change in Acquisitions & Divestments was 200.0% in 2023; the steepest drop was 699.32% in 2023.
- Year by year, Change in Acquisitions & Divestments stood at $5.0 million in 2022, then plunged by 699.32% to -$30.0 million in 2023, then soared by 100.17% to $52000.0 in 2024, then tumbled by 219.23% to -$62000.0 in 2025, then soared by 111.29% to $7000.0 in 2026.
- Per Business Quant, the three latest AGEN Change in Acquisitions & Divestments figures stand at $7000.0 (Q1 2026), -$62000.0 (Q4 2025), and $62000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Agenus | 234.10 Mn | 199.10 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -62,000.00 |
| Dec 31, 2025 | -62,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 264,000.00 |
| Mar 31, 2024 | 264,000.00 |
| Dec 31, 2023 | -29.97 Mn |
| Dec 31, 2023 | -29.97 Mn |
| Sep 30, 2023 | 15.00 Mn |
| Sep 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 10.00 Mn |